affected by lupus nephritis. On light microscopy, epithelial crescents involved 50 to 90% of glomeruli in 36 patients and more than 90% in 16. In 21 of them a mesangial-endothelial proliferation was also present. By immunofiuorscence (39 patients), in nearly all cases a deposition of fibrinogen was seen on the epithehal crescents. This deposition was absent only in cases with advanced fibrohyalinosis or when epithelial crescents were focal. In six patients the deposits of immunoglobulins and complement on the capillary walls were linear: three of them were affected by Goodpasture's syndrome. In the others the deposits were granular with quite different distribution and composition. Twentyseven patients developed acute renal failure; ten of them regained good renal function. Fourteen patients developed progressive renal failure leading to uremia after a period of time from a few months to two years. In 11 patients no renal failure was observed and only abnormal urinary findings were persistently present. Conclusively, some observations can be made: 1) GN with epithelial crescents is an histological definition which includes different clinical and etiological conditions. 2) Among these nephropathies, under the histological and clinical aspect, a clearcut distinction between the primary forms and those secondary to systemic diseases was not observed. 3) Most of the patients showed, as a common characteristic, a severe clinical picture at the onset and a poor prognosis. 4) The severity of evolution is better related to the diffusion of epithelial proliferation than to other clinical, biological and histological indexes. delphia, Pennsylvania, U.S.A. Liver disease with portal hypertension may result in renal functional alterations characterized by decreased renal blood flow (RBF), decreased glomerular filtration rate (GFR) and oliguria with systemic hypotension (" hepatorenal syndrome"). Acute portal vein constriction (PVC) in 16 anesthetized dogs resulted immediately in a similar decrease in mean arterial pressure (MAP) (142 to 104 mmHg), RBF (312 to 204 ml/min) and GFR (47 to 15 mi/mm) and sodium and water retention. Plasma volume expansion (Dextran-40) during PVC, sufficient to return MAP and RBF to control levels, did not correct the depressed GFR, urine volume (UV) and sodium excretion. Therefore, decreased GFR and antidiuresis during PVC are not solely the effect of hypovolemia due to splanchnic venous pooling. Infusion of pitressin, 0.4 pressor U/mm, into the superior mesenteric artery in six dogs during PVC resulted in a progressive decrease in portal vein pressure (35 to 23 cm H20) associated with a progressive and parallel increase in GFR (17 to 67 mI/mm) and UV (0.4 to I mI/mm) over a 30-mm period. Increase in GFR and UV occurred even in the absence of elevation of MAP or RBF. Discontinuation of pitressin infusion with continued PVC resulted in a decrease in GFR and UV to preinfusion levels over a 40-mm period. Release of PVC resulted in a return of MAP, RBF, GFR and UV to control levels, There was a linear inverse correlation between portal vein pressure and GFR in all cases. In conclusion, a splanchnic-renal reflex initiated by portal hypertension and resulting in a suppression of GFR and UV is postulated. Such a reflex may play a role in the pathophysiology of the hepatorenal syndrome.
Metastatic calcification of the lung in 17 patients on repetitive hemodialysis. M. Bestetti-Bosisia, G. Sorgato, M. Romagnoni and G. D'Amico. Istituto di Anatomia Patologica, Ospedale San Carlo Borromeo and Divisione di Nefrologia e Dial/si, Ospedale San Carlo, Borromeo, Italy. Published cases of pulmonary calcification in patients on maintenance hemodialysis are few and its radiographic demonstration by chest roentgenogram during life is exceedingly rare. This report deals with correlation between the postmortem pulmonary findings and some clinical and radiographic data concerning 17 patients receiving repetitive hemodialysis in our Service, who died during the period 1967 through 1973. At autopsy, four of the 17 patients were found to have calcification of the lungs. This finding was correlated with the incidence of metastatic calcification of other organs and with the evidence of bone disease associated with secondary hyperparathyroidism, detected by X-ray examination during life. In our patients, pulmonary calcification was not related with clinical and X-ray evidence of bone disease associated with secondary hyperparathyroidism.
Dialysate regeneration by recirculation on activated charcoal: Eighteen months of clinical experience. M. Biagini, R. Bargagna, T. Cerrai, P. Luboz and E. Denti. Divisione Nefrologica "G.
Monasterio", Ospedale Generate Regionale, Reggio Calabria and Sorin, Societd Ricerche Biomediche pA., Saluggia, Italy. Various types of activated charcoal exhibit desirable adsorbent properties with respect to organic molecules in acqueous solution. This property can be used to remove organic uremic toxins by recirculation of the dialysate over a cartridge of activated charcoal. The dialysis conditions were chosen on the basis of in vitro tests carried out to ascertain the effect of the operating conditions on the electrolyte equilibrium and on the removal of uremic toxins. Since the complete range of organic uremic toxins is not known, the authors maintain that a new purifying procedure must be evaluated by means of long-term clinical trials. The paper gives the experimental results of dialyses using 50 and 30 liters of dialysate, for three patients treated for 15 to 18 months. Using the described procedures, a good removal of creatinine and urate was obtained, while the removal of urea was less good. Clinical evaluation was based on the patients' states of well-being, the degree of work rehabilitation, peripheral nerve conduction, hematocrit value and other factors. The results show that the reduction of the dialysate to 50 liters, which is regenerated with active carbon, allows a state of well-being, and a rehabilitation comparable to those of traditional treatment methods, Reuse of the hollow fiber artificial kidney after cleansing with 0.25 M NaOH. M. Biagini, C. Zoccali, R. Bargagna, T. Cerrai and 0. Maggiore. Divisione Nefrologica "G. Monasterio", Ospedali Riuniti, Reggio Calabria, Italy. The purpose of the present work was to find a method to reuse the hollow fiber artificial kidney (HFAK) which fulfills the requisites of being efficient, safe for the patient and cheap in operational cost. Among the various procedures adopted, cleansing with 0.25 M NaOH best fitted these requisites. The evaluation of the cleansing procedure was based on the changes in HFAK volume and the in vitro dialysance of small and middle molecules. Using the 0.25 M NaOH cleansing method, the volume loss (mean, 32.3%) occurring after each dialysis was almost completely regained as well as the decrease in the dialysance of small and middle molecules. No pyrogenie reaction has been observed; the hematocrit value and the nerve conduction velocity improved or remained unchanged with respect to the control period. One patient developed cardiac tamponade due to hemorrhagic pericarditis which was successfully treated by partial pericardiectomy. During dialysis heparin dosage was kept at levels commonly used for other dialyzers. The cleansing procedure takes one hour for 13 dialyzers. It has ben employed for one year on 35 patents for a total of 1633 dialyses, each dialyzer being reused from 2 to 12 times (mean, 4.46) . With the use of this procedure, marked cost reduction is obtained.
A new way to regenerate the dialysis fluid. L. Bigi, E. Petrel/a and G. Orlandini. Sezione Emodialisi Ospedale Civile Piacenza, Laboratori Bel/co, Miranda/a, Italy. Many previous experiences have proved the ability of activated carbon to retain great quantities of uremic toxins. Urea and phosphate removal represent the major obstacle which previous systems resolved inadequately or with undesirable side-effects (removal of Ca, Mg) likely associated to toxic reactions, In our system 10 liters of dialysate is recirculated from a reservoir through a cartridge containing activated carbon, superactivated oxystarch (which guarantees urea withdrawal) and other inorganic substances basically composed of aluminum and silicon oxide (which retains phosphates). Dialysate is then passed through the dialyzer and returned to the reservoir, The in vitro and in viva experiments (on dogs) have given optimum results on uremic toxin removal. A modified formula of dialysis fluid allowed our system to correct the electrolyte abnormalities and to achieve the acid-base equilibrium of the blood. No signs of toxicity were revealed. This new system, simple and economical, should be useful for the treatment of acute and chronic uremia.
Morphological aspects of bone tissue in chronic renal failure conservatively treated and in regular dialysis treatment: A histological, electron microscopic and histochemical study. G. Bonucci, G. Mioni, A. Castellani, R. Maiorca, G. Maschio, A. D'Angelo, E. Ossi, A. Lupo and E. Va/vo. Istituto di ,Anatomia Patologica, Cattedra!, Università di Roma; Divisione di Nefrologia, Spedali Civ i/i, Brescia; and Istituto diPatologia Medica dc/I'Università di Padova, Italy. The histological, electron microscopic and histochemical aspects of bone tissue, obtained by needle biopsy from the iliac crest, have been studied in two groups of patients with chronic renal failure. Thefirst group consisted of 40 patients with chronic renal failure of diverse etiology, conservatively treated for one to five years and on a low-protein diet (24 to 35 g of protein/day). Their age ranged from 24 to 58 yr, plasma creatinine from 5 to 21 mg/100 ml, and GFR from 25 to 2 mi/mm. The second group was composed of 40 patients receiving regular dialysis treatment for 6 months to 10 yr, their age ranging from 12 to 62 yr. The dialytic treatment was performed three times a week against a dialysate containing 8 mg/l0O ml of calcium. All patients were given aluminum hydroxide. In patients with chronic renal failure conservatively treated, osteomalacia was the main pathological feature (60%). In an additional 15% of the patients, osteomalacia was associated with increased osteoclastic activity and some degree of bone resorption. A mild endosteal fibrosis was found only in two patients. In the remaining patients (25%), the bone tissue was substantially normal. Osteomalacia was found in all patients on regular dialysis treatment. Furthermore, histological signs specific for hyperparathyroidism and mild to severe endosteal fibrosis were observed in 90% of these patients.
Urinary excretion of a-glucosidase, lysozyme and malic dehydrogenase in some nephropathies. L. Campanacci, G. F.
Guarnieri, L. Faccini, G. Bellini and R. Carretta. Institute of Medical Pathology, University of Padua, Italy. The enzymuria must be regarded as a type of proteinuria and, according to the enzyme distribution, it must be similarly classified as "glomerular ", "tubular", "parenchymatous", and "overflow" enzymuria. Enzyme determination in urine is easy, specific, cheap and does not require any urine concentration. Lysozyme (muramidase) and malic dehydrogenase (MDH) are small proteins (P.M. <68,000), which normally filter through the glomeruli and are reabsorbed by the proximal tubules. An increase of these enzymes in urine can be regarded as an index of "tubular proteinuria". On the other hand, a-glucosidase is absent in the plasma and is present in the tubular cells. Its increase in the urine suggests a damage or a lysis of the tubular cells. Lysozyme clearance, MDH clearance and urinary a-glucosidase have been determined in 78 patients with renal diseases, or hypertension or asymptomatic bacteriuria, and in 15 normal subjects. Results are reported in the Table below . Lysozyme and MDH show a similar behavior in the different groups of patients: it is therefore possible to assume that MDH can be regarded as an index of "tubular proteinuria", suitable for clinical practice. Both enzymes allow a quantitative determination of "tubular proteinuria" much easier than the immunological determination of other urinary microproteins. They can be employed as a sensitive method to ascertain tubular damage. Their determination could be of some usefulness in the differentiation between chronic pyelonephritis and asymptomatic bacteriuria. Our data also confirm the presence of an elevated "tubular proteinuria" in patients with renal calculi. a-glucosidase shows instead a different pattern of variation and has probably a different clinical meaning. a-Glucosidase determination in chronic nephropathies seems to be an index of tubular damage less sensitive than lysozyme and MDH. On the other hand, a very sharp increase of a-glucosidase has been reported in acute tubular necrosis. We agree with Ceriotti et al that a "tubular" pattern of enzymuria (lysozyme and MDH) is present mainly in chronic atrophic tubular lesions, while a parenchymatous enzymuria (a-glucosidase) can be observed mainly in tubular acute or subacute lesions of degenerative or necrotic nature and its excretion rate depends on the tubular cell mass and the degree of cell damage.
Renal metabolism of plasma proteins ranging from 10,000 to 45,000 in mol wt. G. C. Carrara, P. Dall'Aglio, P. G. Poiselti, E.
Petrel/a andL. Scarpioni. Sezione di Emodialisi e Divisione Medica II, Ospedale Civile di Piacenza and C/mica Medica II, Universitâ degli Studi di Parma, Italy. Some plasma protein fractions have been determined by means of the radial immunodiffusion method in healthy subjects and in patients with kidney diseases and different degrees of renal failure. All kidney diseases with high proteinuria have been excluded. Plasma concentrations of prealbumm, hemopexin, transferrin, a1-glycoprotein, 2-glycoprotein I, retinol binding protein, 2-HS-glycoprotein and lysozyme have been evaluated. Mean values obtained in three groups of subjects, i.e., healthy individuals, renal patients with serum creatinine< 5 mg/lOO ml and those with serum creatinine> 5mg! 100 ml, were compared. The analysis of variance has shown a significant increase of a1-glycoprotein, 2-glycoprotein I and retinol binding protein in renal patients, in those with high degrees of renal failure. By means of the same comparison, significant decrease of hemopexin, transferrin and a2-HS-glycoprotein has been pointed out. Within the renal patients, highly significant correlations have been shown between the logarithm of serum creatinine and ai-glycoprotein, 2-glycoprotein I, a1-antitrypsin, retinol binding protein and lysozyme. Some considerations of these plasma proteins on renal metabolism are discussed.
Membranoproliferative glomerulonephritis: A study of 45 cases.
P. Dall'Aglio, G. Olivetti, C. Buzio and M. Borghi. II Clinica Medica Università di Parma, Anatornia Patologica Universitd di Parma, Italy. Forty-five cases of membranoproliferative glomerulonephritis have been studied from the anatomical and clinical points of view. The diagnosis was made on renal biopsy specimens by light microscopy in the majority of cases; sometimes, however, the electron microscopy was necessary for final diagnosis. In all cases light microscopy showed irregular proliferaction of mesangial cells and thickening and sometimes duplication of basement membrane. Electron microscopy showed that thickening and duplication of basement membrane was due to the interposition of mesangial material between the capillary basement membrane and the endothelium; the localization of the deposits was studied by this technique. Immunofluorescence revealed an important fixation of 1C and, to a lesser degree, of other immunoglobulins; the fibrinogen fixation was irregular in extension and frequency. Patients were followed up to seven years by some clinical indexes such as the serum complement concentrations and, in some cases, the fibrinogen degradation Medica (Direttore Prof A. Fieschi), Italy. The arteriovenous difference across the kidney, liver and forearm of glutamine, glutamate and ammonia was measured in eight normal subjects and in five normal subjects with ammonium chloride-induced chronic metabolic acidosis. In normal subjects the renal extraction of glutamine was 32 smolesfml. This amount amply accounts for the ammonia produced hy the kidney (35 molesfml). In ammonium chloride acidosis the extraction of glutamine increases significantly (50 limoles/mI) with a parallel increase in renal production of NH3 (125 izmoles/ml). However, a portion of this increase (about 20°,') cannot be accounted for by renal extraction of glutamine only. The amount of NH3 not derived from glutamine and the total renal production of NH3 show a linear correlation indicating that when the production of NH3 increases, a growing quantity of NH3 is derived from substrates other than glutamine. The extraction of glutamate cannot explain this portion of nonglutaminic ammonia. Muscular tissue produces glutamine (56 tsmoleslml) and utilizes glutamate and ammonia. In metabolic acidosis the muscular production of glutamine (80 izmoles/ml) seems to increase, compared to that in the normal group, meeting enhanced renal demand for substrate. The liver, both in normal conditions and in metabolic acidosis, does not release glutamine into the circulatory system, hut glutamate. The blood pH is not responsible for the increased muscular production of glutamine in metabolic acidosis. In respiratory acidosis, in fact, at the same pH, the production of glutamine seems less than in metabolic acidosis and less than in normal subjects.
Landry-Guillain-Barrd-Strohl syndrome in rheumatoid purpura with acute glomerulonephritis. G. Di Filippo, G. Pincella, F. Fdoramo, C. Dadone, S. Sforzini, D. Limido, R. Mimmo and B. Redaelli. Servizio di Nefrologia Ed Emodialisi, Ospedale Generale Provinciale, S. Gerardo dei Tintori del Circolo di Monza, Italy. LOBS polyneuritis is marked by an infectious prodrome of a viral, nonspecific nature, gradually involving the peripheral nervous system. Only over the last few years have repeated reports been made of renal lesions in polyradiculoneuritis. Presentday thinking links the pathogenesis of the nerve and kidney lesions with the formation of antigen-antibody complexes. A case of LOBS syndrome occurred in this hospital in a subject with rheumatoid purpura and acute glomerulonephritis. In April-May 1973, a 72-yr-old man presenting with fever, joint pain, petechiae and edema of the legs was diagnosed as having rheumatoid purpura. At the end of June, the patient showed a high blood nitrogen concentration and oliguria, and was thus transferred to this department. On admission, he was anasarcous, hypertensive, with high blood nitrogen; FG, 47 ml/min; serum creatinine, 2.1 mg/lOO ml; Ra test, + + +; PCR, + +; hematocrit, 26%; plc, 80 mg/bC ml; total protein, 5.2 g/bOOml; albumin, 3.22; al, 0.25; a3, 0.67; , 0.52; y, 0.52; alb/glob, 1.63; WBC, 17,000; uric acidemia, 13 mg/100 ml; BUN, 170 mg/ 100 ml. Urinalysis showed 2 + proteinuria; electrophoretic tracing, nonselective; layer of red blood cells in the sediment; numerous leucocytes; hyaline casts; urine urea, 8 g/ 100 ml; Na, 23; K, 40; Cl, 9 mEq/24 hr. Urine culture was positive for Aerobacter aerogenes, sensitive to nalidixic acid. Treatment was started with spironolactone, diuretics and nalidixic acid. After a fortnight the patient showed another burst of petechiae on the trunk and legs, worsening of renal function and flaccid tetraparesis with loss of deep tendon reflexes in the arms and legs. On spinal puncture, no increase in pressure was noted; spinal fluid was normal, except for slightly high albumin content (200 mg/ 100 ml).
Bone scanning in the diagnosis of renal osteodystrophy. M. Fusaroli, L. Fabbri, B. Bellanova, P. Paul/ca and P. Zucchelli. Malpighi Hospital, Department of Nephrology and Dialysis, Italy. We have evaluated the frequency of clinical and radiological signs of renal osteodystrophy in a group of 42 patients in renal dialysis therapy from one to six years, relating such findings to data obtained from percutaneous biopsy of the iliac crest, The patients have been divided into three groups: 1st group: lack of clinical and radiological symptoms ascribing to the skeletal system; 2nd group: positive clinicnl findings and negative findings on hone radiographs; and 3rd group: presence of clinical and radiological symptoms of renal osteodystrophy. All the patients successively underwent bone scanning. From this study the following correlations have been taken: 1) The bone scanning has presented data well in agreement with the other indexes in the third group of patients. 2) A normal bone scan is usually accompanied by normal clinical-radiological and biopsy findings. 3) In patients with normal radiographs and moderate histological signs of osteodystrophy, the bone scan has pointed out a significant increase of radionuclide uptake in one or more skeletal areas. We conclude the following: a) The osteodystrophic lesions in the initial phase are often revealed earlier with bone scanning than with radiographs even when particularly accurate. b) The bone scan, even when showing diagnostic elements in themselves nonspecific, permits a more precise evaluation of the site and extension of the lesion, and it allows the execution of a radiological study with eventual stratigraphic examinations focused on the site of augmented accumulation of radionuclide. The histological examination, however, remains fundamental for a qualitative and quantitative diagnosis of the bone lesions.
Dialysis performance in waste materials removal according different treatment schedules. N. Gargano, M. Grani and F. Vagnoli. Divisione di Nefrologia, Ospedale S. Maria Sopra i Ponti, Arezzo, Italy. Optimum hemodialysis in uremic patients is likely the intersection point between maximum waste materials removal and minimum loss of physiologic or useful substances.
As the exact cause of the uremic syndrome has not yet been identified, dialytic strategies now on trial are only empiric attempts to hit an unbocated target. In spite of that, effective studies of waste material extraction, during dialysis hours and as total removal in the week, may be of some value in dialysis performance assessment. Effective removal of urea and creatinine was measured in patients treated with hemodialysis according to different schedules: twice a week, three times a week and every other day (QD=600; Q 300-350; Gambro Lundia Nova dialyzers). Dialysate was completely collected from drain every hour; volumes were carefully measured and samples obtained for chemical analysis. Hourly urea and creatinine net output was easily calculated. Urea and creatinine concentration in arterial blood was determined at the midpoint of dialysate collection time; clearances were directly calculated by the ratio dialysate minute output 100/plasma concentration. Maximum urea and creatinine output occurred in the first dialysis hour and values correlated with plasma concentration. Extraction decreased in the following periods, creatinine decreasing more slowly than urea. In patients receiving dialysis three times a week, second hour urea extraction was 60 to 70% as compared to the first hour= 100, and 35 to 45% during the fifth hour; second hour creatinine extraction was 70 to 75%, and 50 to 60% during the fifth hour. For an equivalent weekly dialysis time, maximumurea and creatinine output was obtained by increasing dialysis frequency, and maximum weekly urea and creatinine output was di Nefrologia e Dialisi deIl'Ospedale Policlinico, and Ospedale Pediatrico Reg. Elena, Milano, Italy. Primitive proximal renal tubular acidosis (RTA) is a rare disease of infancy and childhood. So far, only a few cases have been reported. Primitive proximal RTA is characterized by hyperchloremic metabolic acidosis with low renal threshold for bicarbonate and normal glomerular filtration rate. Excessive vomiting, fever and growth retardation are the commonest symptoms. A delayed diagnosis may cause severe skeletal deformities in addition to failure to thrive. Primitive proximal RTA has been considered by some authors to be a transient disease with spontaneous recovery and somatic growth, but this recovery has never been well documented. Indeed, some patients have retained a permanent defect. Two kinds of treatment have been proposed for this syndrome: a) the administration of alkali doses as high as needed to maintain blood bicarbonate within the normal range and b) the use of thiazidic diuretics. (By reducing extracellular volume they would increase renal bicarbonate threshold and reduce calciuria which often is high in these patients.) A four-year-old girl with primitive proximal RTA, who presented with retarded growth, excessive vomiting, fever and skeletal lesions with radiological evidence of rickets, has been followed-up for three years. The last symptom, typical of distal RTA, may be attributed to the late diagnosis with the consequent protracted acidosis. No signs of impaired renal function were present except for a low bicarbonate threshold. The salt-water depletion, caused by vomiting, contraindicated the use of diuretics for fear of worsening the state of hydroelectrolytic unbalance. However, the high alkali dosesnecessary to normalize the blood bicarbonate-gave rise to gastric complaints; furthermore, it caused a persistent high bicarbonate excretion with consequent renal stone formation and urinary tract infections. The blood pH, through the consequent hyperventilation, was normalized by the administration of 2 mEq/liter/day of sodium bicarbonate; after this treatment growth resumed, length and weight reached normal values for age, skeletal lesions improved and there was recovery from rickets. Investigations of bicarbonate reabsorption performed after two years of therapy showed an elevation of renal bicarbonate threshold towards normal values. The current normal biochemical and acid-base pattern shows that the patient is completely healed of the RTA.
Growth failure in children with chronic renal disease. R.
Gusmano, F. Perfumo, U. C. Basile, L. Formicucci andL. Macciô. Pediatric Medical Division, Section of Nephrology and Hemodialysis, G. Gaslini Institute, Genoa, Italy. Many factors such as acidosis, chronic malnutrition, anemia, chronic infection and osteodystrophy contribute to growth failure in children with renal disease. In 82 children, with primary or secondary renal disease, we have investigated the incidence on growth of some of these factors. Children with gross proteinuria, nephrotic syndrome or receiving long-term steroid therapy were not included in the study. Twenty-six children with congenital or acquired obstructive uropathy have been studied to evaluate the importance of some factor, particularly chronic urinary infection. Growth failure was present in 59% of all cases.
Furthermore, 11 out of 15 patients began to grow normally after surgical correction and resolution of chronic infection.
An investigation of the growth of 30 children with re3:l disease who fulfilled the following criteria was made: history of renal disease of a minimum of two years' duration and a reduction of renal function. In all cases the GFR was 70 ml/min/l.73 sq m or less. The children were divided into two groups: in group 1 the nephropathy dated from infancy; in group 2 the onset of renal disease occurred later in childhood. The duration of disease could not be correlated with the severity of the height deficit, whereas a poor renal function early in life, when the growth velocity is greatest, causes a more profound growth failure. In the short stature of children with renal disease, osteodystrophy plays an important role. The existence of renal rickets, even in the absence of severe skeletal abnormalities, was associated with the most severe growth failure. Deceleration of growth has been observed when renal failure progresses; with the reduction of GFR below 20 ml/min/l.73 m, 70% of the children had a growth velocity of less than 65% of that normally expected for their age. The problem of growth in children receiving renal dialysis therapy (RDT) remains unsolved. The growth pattern of 26 children receiving maintenance hemodialysis from six months to five years has been investigated. Our own data show a growth velocity of 50% of that normally expected for their chronological age. Nevertheless, this mean value originates from extremely different limits. In three subjects we observed a catch-up of growth, while three children grew very poorly. In addition, a reduction of the growth velocity after the first 9 to 12 months of dialysis has been noted, virtually in all children. The impossibility of maintaining under strict control the many factors involved in growth explains this slowing up. A reduced secretion of human growth hormone (HGH) appears not to be involved in the growth failure. In our patients receiving RDT, we have demonstrated values of HGH greater than in normal subjects after stimulation with orally administered L-dopa. The advantages of this method, which does not require a stimulation of carbohydrate metabolism, are several: direct stimulation without intermediate metabolites, which could be modified by uremia or by dialysis; absence of side-effects; and indirect exploration of GH releasing factor.
Glomerulonephritis associated with ventriculo-atrial shunt infection. E. Imbasciati, F. Gaboardi, A. Tarantino and M. Bardare.
Sezione di Nefropatologia, Ospedale Policlinico di Milano, Clinica Pediatrica deli' Università di Milano, Milan, Italy. Three patients (aged 4, 22 and 24 yr), affected by infection of ventriculo-atrial shunt for hydrocephalus, developed the nephrotic syndrome. Two patients had an acute onset with gross hematuria and hypertension. The renal biopsy specimen showed on light microscopy a membranoproliferative glomerulonephritis in all three patients. On immunofluorescence coarse granular deposits of immunoglobulin and complement were found on capillary loops of the glomeruli. In one case, an electron microscopy study was performed and subendothelial electron-dense deposits with mesangial interposition were demonstrated. All patients presented with hypocomplementemia. The clinical course of this nephropathy has been followed for more than one year after the renal biopsy. The patients have been treated with immunosuppressive drugs and steroid therapy without any results. The renal symptoms improved after effective antibiotic therapy, but relapses of infection were followed by worsening of the nephrotic syndrome. The infected valve was removed; a Staphylococcus was demonstrated in two cases. Lasting control of the infection led to a complete remission of the glomerulonephritis in one subject and to a striking improvement of the laboratory findings in the second one. The third patient died because of surgical complications which followed the prostheses substitution. Our observations suggest a close relationship between infection and activity of the nephropathy. A complete remission of the glomerulonephritis after definitive removal of the infection is likely to occur.
A new vascular device, fistula catheter-like, for periodic hemodialysis. G. La Greca, G. Bazzato, S. Biasioli, E. Botti, U. Co/i, A. Fabris, P. Gaianigo and E. Pisani. Division of Nephrology, S. Bortolo Hospital, Vicenza: and Department of Surgery, University of Parma, Parma, Italy. We describe the surgical procedure, the modality of uses and acquired experience with a new vascular prosthetic device (Sparks-Mandril) employed in a repetitive hemodialysis patient with serious vascular problems. The mandril consists of a flexible silicone rod over which two Dacron layers have been placed. The subcutaneous tunnel is formed by introducing a hollow stainless-tube near two vascular branches, arterial and venous vessels, in the forearm or in the leg. For the graft to mature and to obtain an intimal fibroblastic proliferation, almost a 60-day period is necessary. A short incision was made near the graft heads; then the silicone mandril was re- kalemia, metabolic alkalosis, polydipsia and polyuria was admitted to our Department. Clinically, the patient showed reduced body growth, weakness, anorexia, hypotension and was mentally normal. Renal function was investigated and appeared to be normal, while i.v. pyelography showed sponge kidney. Daily urinary output was about 5000 ml. A regular ad lib diet was started. Supine plasma renin activity (PRA) was 22.8 ng/ml/ 3 hr (NV, 1.5 to 4); aldosterone, 21 ng/l00 ml (NV, 3 to 18); upright PRA was 45 ng/ml/3 hr (NV 8); aldosterone, 72.3 ngf 100 ml (NV, 3 to 18); urinary aldosterone was 15.4 g/24 hr (NV, 5 to 15 Histological examination showed a proliferative glomerulonephritis associated with marked juxtaglomerular hyperplasia; on electron microscopy electron-dense deposits, including fibrin, were found within the basement membrane.
Immunofluorescence technique revealed IgG, IgA and 1C areas.
We outline the singularity of this clinical picture (Bartter's syndrome plus sponge kidney). Histological findings and pathophysiological aspects are discussed.
Studies on some coagulation factors in chronic uremics receiving conservative therapy and dialysis. S. Lamperi, P. Muttini, P. over the liver and twin-coil ifiter were made. The patients to whom labeled platelets had been administered showed a more rapid exponential decrease of plasma radioactivity than the controls; this decrease was more evident in the uremics receiving dialysis than in those receiving conservative treatment. This finding was confirmed by surface measurements which showed an increase of the radioactivity over both the arteriovenous by-pass and the twin-coil filter. Also, the curves of serum fibrinogen radioactivity showed sharper decreases in the uremics receiving dialysis than in those receiving conservative therapy. Our research suggests that these differences are related to rapid decreases of the radioactivity during dialysis. This finding is only partly justified by the radioactivity present in the twin-coil filter, while in the liver there is a larger radioactive depot which can suggest an accelerated parenchymal metabolism of fibrinogen.
Transparietal pyelography in urological patients with advanced uremia. 0. Maggiore, M. Biagini, C. Delfino, G. Monzani, S. Sisca and F. Pizzarelli. Divisione Nefrologica "G. Monasterio", Ospedali Riuniti, Reggio Calabria, Italy. The identification of urinary obstruction in patients with severe renal failure requires a high degree of diagnostic suspicion on the part of the nephrologist and the use of adequate radiological techniques. Pyeloureterography with high doses of contrast agent, preferably after vigorous hemodialysis, and ascendent pyelography are generally adopted; however, these techniques may give misleading results and are not without risk for the patients. This paper describes our experience in the use of transparietal pyelography on 23 patients with renal failure, the majority of whom (19) were in advanced uremic stage (plasma creatinine from 10 to 21 mgI 100 ml). The adoption of this diagnostic procedure was based on the following criteria: a) a history of typical renal colic and/or spontaneous elimination or surgical asportation of stones; b) the presence of opaque shadows on presumed urinary tract; C) unequal size of the renal shadows at tomography; d) a history of iatrogenous events or of a disease liable to cause obstruction of the urinary tract. Transparietal injection gave positive results in 22 out of 23 patients. All patients on whom it gave positive results showed very dilated caliceal cavities. In the one patient in whom the result was negative, the obstruction showed by other techniques was of recent onset and had caused a slight dilatation of the pyelocalyceal cavities. In the majority of cases the obstruction was due to radiotransparent (9) or radioopaque (5) stones. In the remaining cases the obstruction was due to cancerous infiltration, retroperitoneal fibrosis, neurogenous bladder, urinary tuberculosis or prostatic hypertrophy. Using this technique, it was possible to supply valuable information for the surgical approach. In only one case was blood transfusion necessary, owing to a fall in the hematocrit. When one considers the total number of patients on whom this technique was used (73, including nonuremic patients), the incidence of this complication can be considered irrelevant. Our experience shows that this radiological technique has a higher diagnostic value than other techniques on patients with obstructive nephropathy in the uremic stage. It should be adopted in all nephrologic units since nowadays it is to these clinics that patients with uremia, whatever its cause may be, are referred.
Long-term propranolol treatment of resistant arterial hypertension in hemodialyzed patients. 0. Maggiore, M. Biagini, C. Zoccali, M. Misefari and S. Sisca. Divisione Nefrologica "G. Monasterio", Ente Ospedaliero Regionale di Reggio Calabria, Italy. Bilateral nephrectomy is a procedure currently used in uremic patients whose arterial hypertension cannot be controlled by adequate regular dialysis treatment. The present work was undertaken to see if arterial hypertension of chronic uremics can be controlled with long-term administration of propranolol, a drug which is known to suppress renin secretion. The drug was given to seven patients chosen from 51 hemodialyzed uremics because of their resistant arterial hypertension. All seven patients had diastolic pressures above 130 mm Hg, grade 3 to 4 retinopathy and severe hypertensive cardiomyopathy. Attempts to control their blood pressure by increasing sodium depletion with intensive ultrafiltration and severe dietary sodium restriction, as well as with other antihypertensive drugs, were completely unsuccessful. The patients were then treated with propranolol (160 to 400 mg/day). Diastolic blood pressure dropped to normal values (590mm Hg) in all of them (P<0.00I). Plasma renin activity decreased from the mean pretreatment value of 8.70 2.19 ng/ mi/hr to 4.82 4.07 ng/ml/hr (P< 0.025). Compliance of arterial pressure with drug treatment was assessed several times in each patient. Drug discontinuation resulted in a prompt rebound of arterial pressure to pretreatment values. However, hypertension was always controlled again on resuming drug treatment. Presently, the duration of treatment ranges from 5 to 12 months, and its effect on blood pressure remains unchanged. No adverse effect has been noted up to now. All patients are well and fully rehabilitated. These results show that adequate pharmacologic control of so-called renin-dependent hypertension can be Two distinct groups of patients have been seen; in the first group, acute renal failure follows early shock and is readily settled by the shock therapy; in the second group, kidney damage shows the same onset as liver damage, with an extended clinical course and late polyuria. Sometimes, some tubular function involvement persists. All the patients have a remarkable hypercatabolism, with significant weight loss. Liver damage rarely shows evidence of cytolytic involvement as can be seen by serum enzyme determinations. Serum bilirubin is not correlated with the clinical course of acute renal failure. There is a disorder of hemostasis characterized by a remarkable thrombocytopenia that is readily reversed in the patients who are dialyzed early. Intravascular coagulation was present in only one patient (who subsequently died) with a decrease of C3, but not of C4. In the other patients, intravascular coagulation was not important in the pathogenesis of the disease. Prognosis is strictly affected by early dialytic therapy. The fact that this treatment is very important for kidney and liver damage, and for thrombocytopenia, strongly supports the hypothesis of a leptospirosis toxin. Most of the healed patients have good renal function; others, with later therapy and a more serious clinical course, show a refractoriness of the renal tubules to ADH and a de- 21 patients with renal function below 14 mI/mm, receiving twice-weekly standard Kiil hemodialysis treatment. These patients had been treated for an average of 21 months. The third group, consisted of 15 patients with renal function below 10 ml/ mm receiving thrice-weekly hemodialysis therapy with a coil dialyzer. These patients had been treated for an average of seven months. The third group included seven patients previously treated with dietary therapy and eight patients previously treated with bi-weekly hemodialysis. We think it is reasonable to conclude the following on the grounds of our present study: 1) The well-known alterations of glucose metabolism are stressed in the first group and observed, in a less proportion, in the second one. On the contrary, in the third group, we have noted an important improvement of glucose metabolism in all the patients, independent of previous treatment. 2) Blood values of IRI were variable and of less significance in the three groups; but the IRI/ glucose rate suggests a marked improvement in patients on threetimes weekly hemodialysis treatment compared with the other patients of the first two groups. Besides, in the third group, the IRI was almost normal in patients below 40 yr of age; the IRI was slightly altered in those over age 40.
3) The patients of the first and second groups had a markedly altered fasting lipid pattern, chiefly in the TG level. The value of the TG was lower in the third group than in the first two groups, but higher than the normal value. After the glucose load, a marked elevation of TG in the patients with an altered fasting TG level confirmed the clinical usefulness of the three-times weekly hemodialysis treatment. Few modifications were observed, after glucose loading, in those patients with a nearly normal fasting TG level. The possible pathways of these uremic metabolic alterations are discussed. The importance of these findings are stressed, as they may aid understanding of the clinical uremic pattern and assist in the choice of the most therapeutic treatment. to the double stable strontium tests, i.v. and p.o. Sr , 10 mEq, was iv. infused, and its disappearing plasma curve studied at ten hours after infusion. Four days after, Sr , 30 mEq, was administered by mouth to fasting patients, and the subsequent plasma curve was studied at ten hours after infusion.
As Sr + is completely dialyzed, results of the second test which was performed, after two dialyses, were not affected by the first. By means of a simplification of the deconvolutional integral calculus, the absorbed fraction of the administered dose was evaluated from both curves. The disappearing Sr + curve from plasma, plotted as power function, was also used to calculate 1) the "continuously expanding pool of calcium, expressed in total plasma units (TPU), and, consequently, 2) the accretion rate of bone (Ca B) in TPU. Under our experimental conditions, Sr + behaves like Ca as far as intestinal absorption is concerned in fasting patients. Moreover, the intestinal excretion of Sr + + from blood is similar to that of Ca within 24 hr after iv. injection. Intestinal absorption ranged between 33% (normal value) and l2%, of the administered dose, while exchangeable Ca (CaE) reached 60 TPU values (NV, 16 TPU), and CaB, 16 TPU (NV, 0.8 to 2 TPU). These metabolic aspects are in agreement with histological patterns of serious osteodystrophy (concomtitant osteomalacia and resorption) and with reduced calcium, nitrogen and phosphate contents, per 100 g of tissue. These results are discussed also in the light of bone densitometry, diet composition and dialysis duration.
Relationships between glomerular hypercellularity and proliferation: Fine structural findings in membranoproliferative glomerulonephritis. G. Monga, M. G. Canese and F. Mollo. Centro di Microscopia Elettronica della Facoltd di Medicina, I e III Cattedra di Anatomia e Istologia Patologica, Torjno, Italy. The term "proliferative glomerulopathy" is usually employed to indicate glomerular pathological changes characterized by hypercellularity; nevertheless, the actual proliferation by glomerular cell division has been questioned (Galle P: Actualitds ndphrologiques de l 'HOpital Necker, p. 263, 1970) : according to several authors, exudation with infiltration of the mesangium by mononuclear blood cells should be alternatively considered. Light microscopic investigations demonstrated mitoses in hypercellular glomeruli, but did not clarify the endothelial or mesangial nature of proliferating cells. By electron microscopy, the occurrence of glomerular cell mitoses in glomerulonephritis has been described in human endothelium (Mollo F, Monga G, Canese MG: Virchows Arch Abt B Zellpath 11: 198, 1972) , as well as in mesangial and endothelial cells of the rabbit (Johnston WA, Latta H: Lab Invest 26: 741, 1972). More evidence may likely be accumulated about the actual cell proliferation in hypercellular glomerulopathies; investigations have thus been undertaken in our laboratory using several methods, on human and experimental material. A new observation of a glomerular cell mitosis in membranoproliferative giomerulonephritis is presented here: a glomerular cell in metaphase was observed along the glomerular basement membrane in subendothelial position; it was partly surrounded by rather electron-dense fioccular material, and partly by mesangial-like matrix. Any direct relationship with the capillary lumen could not be substantiated.
The discussion of fine structural details suggests that we are dealing with a mesangial cell dividing into the wall of a glomerular capillary, This new finding 1) unquestionably supports the possibility of actual cell proliferation in glomerulonephritis, and 2) demonstrates the occurrence of mesangial cell proliferation, as an explanation of the mesangial cell interposition in membranoproliferative glomerulonephritis; such proliferation is thus morphologically proved and not only supposed on the basis of hypercellularity.
Effect of carbamoyl-dibenzoazepine (Tegretol) and of ethyl-pchloro-phenoxy-butyrate (Clofibrate) on the urinary excretion of water and solute in pitressin-deprived diabetes insipidus (DIPP). A. Novarini, G. Bruschi, P. Coruzzi, A. Montanan, E. Rossi and A. Borghetti. Istituto di Clinica Medica /10 and Instituto di Semejotica Medica, Università degli Studi di Parma, Parma, Italy.
In addition to the classical therapy of DIPP with antidiuretic hormone, there are other therapies with diuretics and, in recent years, with different drugs such as chlorpropamide (Arduino, Reforzo-Membrives; Gilber-Dreyfus e coil.), the carbamoyldibenzoazepine (Delzant e coil.) and more recently ethyl-pchlorophenoxy butyrate (De Gennes e coIl.). In some of these drugs the antidiuretic action is associated with a reduction of glomerular filtrate to larger or lesser degree. This reduction, because of the complex reactions of the meduiar mechanisms, causes difficulty in evaluating factors and its eventual direct antidiuretic action is not readily recognizable. In our clinical observations of DIPP, the net antidiuretic action of both Tegretol and that of Clofibrate is not associated with variations of the GFR. In fact, data demonstrate: 1) reduction of urinary volume (mean values, from 2 to 7 ml/min); 2) reduction of free water clearance (mean values, from 0.9 to 4.9 ml/min); 3) modest variations of osmolar clearance (mean values, from 2.8 to 2.9 ml! mm); 4) no variations of plasma osmolarity, sodium, potassium and hematocrit in the blood; and 5) no modifications of the acidgenetic tubular functions. Clinically, there is disappearance of the feeling of thirst, no variations of blood pressure and a slight increase of body wt in the first few days, linked to a transitory positive water balance. The rapid antidiuretic action suggests an ADH-like action. This action is also studied as a function of the modifications between Cosm and CH2o during variations of hydroelectrolyte balance.
First experiences of a new end-to-end anastomosis without sutures for hemodialysis arteriovenous fistulas. E. Petrella, G. Orlandini, P. G. Poisetti and M. G. Gentile. Sezione Emodialisi Ospedale Civile Piacenza, Divisione di Nefrologia e Dialisi Ospedale S. Carlo Borromeo Milano, Milan, Italy. Performing the vascular sutures is often a serious problem during the surgical preparation of arterioenous fistulas (FAV) for hemodialysis. We suggest a new technique to perform an end-to-end anastomosis by inserting the artery for a 5 to 6 mm stretch into the vein, suitably dilated, and then by cementing the vessels by means of a cyanoacrylic tissue adhesive (Histoacryl, Braun Melsungen). This technique is very simple and the duration of the surgical procedure is reduced by one-half. In six patients thus treated, no complications occurred, either immediately or afterwards. The flow rate of the FAV depends entirely on the arterial caliber and so the risk of cardiac failure by return overload is reduced. This technique is more simple than the usual ones and could be utilized even by medical staffs with little surgical experience.
Prognosis of acute glomerulonephritis in adults. E. Rivolta, E. Imbasciati, L. Guerra and N. Case. Sezione di Nefropatologia, Ospedale Policlinico, Milano, italy. Long-term follow-up of 33 adult subjects with acute glomerulonephritis (AGN) is reported. The patients were selected on the basis of the acute onset of the clinical symptoms and of the histological picture. An intracapillary proliferative glomerulonephritis with or without polymorphonuclear exudation was observed in all initial renal biopsy specimens; epithelial proliferation was present in some cases, involving no more than 50% of the glomeruli. Immunofluorescence studies, performed in 13 cases, showed the typical pattern of AGN. One patient died during the acute phase from sepsis. All of the others have been followed for one to eight years: 15 patients showed a complete remission within a year, and another 9 patients within two years; in the last 8 subjects urinary abnormalities persisted after more than two years; in 2 of these (over 60 yr old) a functional impairment remained. The outcome has been correlated with some findings of the initial phase: no correlation has been observed between the evolution of the disease and antistreptolysin-O-titer, C3 concentration, degree of renat failure or degree of glomerular proliferation, in nine patients a second renal biopsy specimen after one to three years was available: a slight mesangial proliferation with obsolescence of some glomeruli and interstitial sclerosis was found. Immunofluorescence was performed in seven of these patients: in three patients it was negative; in two it evidenced faint deposits of C3, and in the other two it showed deposits of C3 with IgG. Our results indicate that the recovery of AGN in adults often occurs after a prolonged outcome. The persistence of hystological lesions does not seem to have a poor prognosis at least for the period considered. The lack of complete remission seems not to be associated with an evolutive course or with a persistence of an Ca'Granda", Milano, Italy. We have measured the serum concentrations of the components Clq, C4, C3 and C5 of complement and of C3 activator (C3A) in 173 patients, at the time of renal biopsy. We have also studied by immunofluorescence the glomerular deposition of the same complement components and their association with immunoglobulins and fibrinogen. in 10/10 cases of minimal change nephropathies, serum concentrations were normal: in 3/10 cases scanty glomerular deposits of C3, associated with 1gM, were found. in 19/22 cases of focal glomerulosclerosis, focal and segmental deposits of 1gM stained also for C3; Clq and C4 were present in 15/20. In these patients no serum alterations were seen, in 18/18 cases of membranous glomerulonephritis (GN), the complement components were normal in the serum: fixation of antiserum anti-C3 (associated with anti-IgG) was seen in 15/17, of anti-C4 in 7/17 and of antiClq in 5/16. Quite different patterns were observed in 30 cases of acute GN, according to the interval between the onset of the disease and the time of observation: when renal biopsies were performed during the first two weeks (five cases), low serum concentrations of Clq, C4, C3, C5 (and only in one case, of C3A) were found while an isolated bright glomerular staining for C3 (together with less IgG) was observed: in three cases C3A was also present. When biopsies were performed between two and six weeks from onset (three cases), low serum concentrations of C3 and glomerular deposition of C3 were found. When biopsies were performed later in the course of the disease (22 cases), serum concentrations of all complement components were normal and very scanty glomerular deposition of C3 was found. In 7/7 cases of proliferative GN with epithelial crescents, serum levels were normal and glomerular deposition of C3 was present. In 3/7 cases Clq and C4 were also found, even if less intense. In 30/30 cases of focal GN with mesangial deposits of IgA-igG, serum concentrations of all components were normal; C3 alone was present in mesangium. In 16/19 cases of membranoproliferative GN, serum concentrations of C3 were reduced and, in 2/19, also C4. By immunofluorescence, 15/19 cases showed glomerular deposits of Clq, C4 and C3, associated with immunoglobulins, while in the remaining 4 cases, which presented low serum concentrations of C3, isolated deposits of C3 were found. No correlation could be seen between the serum concentrations of the complement components and the glomerular deposition. Ten/20 cases of lupus nephritis showed normal concentrations of C3, while two of them presented low concentrations of Cl q and C4: in all these cases a strong glomerular fixation of serum anti-C3 (associated with all immunoglobulins) was seen; Clq was present in 4/6 and C4 in 5/7. Five/20 cases of lupus nephritis showed low serum concentrations of C3: 2 of them had also low concentrations of Clq, C4 and CS. In all these cases, the deposition of C3 was important, as well as Clq and C4; C3A was seen in one case only. The remaining 5/20 cases of lupus nephritis had serum concentrations of C3 strongly reduced, with low Clq, C4, C5 and, in 3/5, C3A. In these patients, immunofluorescence showed deposition of Clq, C4 and C3: C3A was present in 2 of them. In these last cases there was evidence for an inverse correlation between serum concentrations and glomerular deposition. In 6/10 cases of essential cryoglobulinemia, C3 was reduced in the serum; in 10/10 deposition of C3 was found, in 5/10 of C4, in 5/7 of Clq and in 2/6 of C3A. In 7/7 cases of rheumatoid purpura, serum concentrations were always normal: glomerular deposition of C3 (associated with IgA, lgG, fibrinogen) was observed. Correlations between serum profiles and glomerular patterns of complement components may lead to a better understanding of the immunopathogenetic mechanism of the different glomerular diseases. At the same time, they add helpful diagnostic and prog. nostic information. L. ('agnoli, C. Rovinetti and P. Zuechelli. Department of Nephro. logy and Dialysis, Malpighi Hospital, italy. We describe our findings in 32 cases of membranoproliferative gtomerulonephritis of which 30 were idiopathic and two associated, one with macroglobulinemia and one with cryoglobulinemia mixed, respectively. The diagnosis was based on the clinical data and on renal histological findings, studied by light, immunofluorescent and electron microscopy. The clinical symptoms most frequently observed are arterial hypertension, macrohematuria, the nephrotic syndrome and microscopic hematuria with mild proteinuria. Thc hypocomplementemia, although statistically present with high frequency, is not constant and is more often caused by an activation of the alternate pathway of complement. The type of activa-tion of the complement system, evaluated by serum investigation of the various fractions of the complement and by the immunohistology, does not show a significant correlation to the clinical course of the nephropathy. The steroid and immunosopressive therapy does not seem to influence the course of the disease which also presents art elevated actuarial survival.
Electromyographic indices in the evaluation of uremic peripheral neuron damage during short hemodialysis schedule. G. Savazzi, V. Cambi and L. Migone. Instituto di II Clinica Medico Dell' Universitâ di Parma, Parma, Italy. The maximum motor nerve conduction velocity (Max MNCV), carried out as a routine examination on the ulnar, median and peroneal nerves, has been in the past ten years the major index of the nephrologist for the evaluation of neuron damage. This test, reliable in cases of grave uremic polyneuropathy, has not always demonstrated a clear sensitivity to small variations of the clinical and functional state of the peripheral neuron, once the hemodialytic treatment has been started. The Max MNCV measurement investigates only fibers with very rapid conduction; for this reason such an index can be normal when only few fibers remain intact or partially affected, therefore being able, alone, to support and indicate a normal conduction velocity. On the other hand, when the state of denervation continues in the course of predialytic conservative treatment, the alterations of some muscular fibers can sometimes become irreversible, because of alterations of the motor endplates and modifications of nerve fibers. This condition may explain nerve conduction values seriously and permanently lower, even long after the substitutive treatment has started. Twenty patients who recently underwent dialytic treatment with a short hemodialysis schedule were investigated with regard to modifications of the global electromyographic outlook, during the transitional period between conservative and hemodialytic treatment. Five to 12 months after the start of hemodialysis, we measured the ulnar and peroneal Max MNCV, taking into account also other aspects peculiar to peripheral neuropathy. We have considered the possible correlation existing among electromyographic, chemical and clinical indices, useful for evaluating the efficiency of hemodialysis therapy. In the cases in which the polyneuropathy was characterized by normal or subnormal conduction values, the global evaluation of the morphology of the motor action potential better indicated the true functional modification of the uremic fibers; while the appearance of fibrillation potentials, as well as modifications of the electromyographic scheme and amplitude of potentials during maximal voluntary effort, indicated a more serious peripheral neuropathy in those patients who began receiving hemodialysis therapy before they had become more seriously affected. From our experience we conclude the following: 1) The electromyographic examination allows one to determine with a good degree of certainty the presence of damage in the uremic peripheral neuron, through an analysis of various electromyographic indices, in those cases in which Max MNCV cannot give a clear and sensitive resolutive answer. 2) Uremic polyneuropathy mainly affects and more badly damages the longer fibers: for this reason its seriousness can best be evaluated by peroneal rather than ulnar conduction tests, in the absence of other electromyographic pathologic factors.
3) The electromyographic abnormalities tend to diminish following the start of hemodialysis. Even in the absence of normalization of Max MNCV, clinical improvement of the peripheral nerves in hemodialyzed patients can better be deduced from different electromyographic factors.
Clq deficiency in a case of chronic glomerulonephritis. F. P. Schena, G. Lucivero, M. G. Illuzzi and F. Marzullo. Clinica Medica II and Anatonna Patologica, University of Ban, Bail, Italy. Preliminary findings in a case of chronic glomerulonephritis and Clq deficiency are reported. A 46-yr-old woman had purpura, arthralgias, peripheral neuropathy, hepatosplenomegaly and renal failure. Histologically, the renal biopsy specimen showed a membranoproliferative glomerulonephritis with subendothelial deposits of lgG, 1gM, C3 and fibrinogen; additional complement components were absent. A striking correlation between the immunochemical composition of the glomerular deposits and that of the cryoprecipitate was found. In fact, the laboratory findings showed lgG-lgM cryoglobulin in the serum, a narrow band in the beta zone, a paraprotein-type 1gM line and high levels of rheumatoid factor activity. The most relevant feature was the Clq deficiency, while the C3, C4, C3A and C5 concentrations were very low. The Clq deficiency was demonstrated by immunological methods in the patient's plasma, serum and urine. It appears to be unlikely that the association of Clq deficiency and the manifestations of mixed cryoglobulin and monoclonal gammapathy was coincidental. A strict correlation between Clq deficiency and the low concentrations of other complement components is suggested.
Indomethacin in aminonucleoside nephrosis. Adalberto Sessa, Ferruccio Conte and Aniello Cioffi. Sezione di Nefrologia, Ospedale Generale Provinciale di Vimercate, and Centro di Farmacologb Ce/lu/are del C. N. R., Universitd di Mi/ano, Mi/an, Italy. Some authors have reported an improvement in human chronic glomerulonephritis treated with indomethacin, the most manifest result being a decrease of proteinuria. Some effects of indomethacin are well known. From ultrastructural data of previous work concerning the morphological patterns of renal glomeruli of normal rats treated with indomethacin, we have put forward the hypothesis that this drug may increase the synthesis of glomerular basement membrane by podocytes. To support this hypothesis, we treated rats affected with aminonucleoside nephrosis with indomethacin i.p. (daily dose, 4 mgJkg). We found that in aminonucleoside nephrosis, puromycin is able to induce significant proteinuria because it reduces the basement membrane synthesis by podocytes. In the rats with aminonucleoside nephrosis (12 days) treated with indomethacin (5 days) biochemical indexes in those with nephrotic syndrome have been less altered than in the rats with aminonucleoside nephrosis but without the nephrotic syndrome; furthermore, the fusion of foot processes and the podocytic alterations induced by aminonucleodside nephrosis have been less evident. Moreover, our ultrastructural findings have shown cytoplasmic aspects of podocytes induced by indomethacin: an increase in the number of mitochondria and polysomes, enlargement of the Golgi apparatus and of rough endoplasmic reticulum often containing an electron-dense substance interpreted as "basement membrane material Antirenin activity of practolol in uremic subjects receiving hemodialysis therapy. G. Sp/endiani, U. Giammaria, V. D'Alessandro, G. Marinange/i and F. De Meo. Servizbo di Emodial 1sf, Ospedale Civile "S. Sa/vatore", L'Aguila, Italy. After some short notes on the pathophysiology of arterial hypertension and on the pharmacology of beta-blocking agents, we report the results attained after giving practolol to uremic subjects whose hypertension was not controllable with hemodialysis treatment. The aim of the research was to verify whether practolol had an antirenin action similar to that of propranolol. The observation is based on ten cases: practolol was given at a dose of 400 mg/day orally, four times a day for six days. The attained results may be recapitulated as follows: 1) Practolol exhibited a definite antirenin action, causing a reduction in plasma renin activity between 35 and 90%. 2) The heart rate was lowered systematically showing the blocking of beta-cardiac receptors.
3) The arterial pressure (AP) dropped constantly; the average reduction was 25 mm Hg for maximum AP and 15 mmHg for minimum AP. The findings demonstrate the antirenin actions of practolol, confirm-ing the intervention of beta-receptors on renin secretion. The hypotensive action obtained with the beta-blocking treatment may be caused not only by the inhibition of renin activity but also by the decrease of the minute volume by the lowering of cardiac frequency and heart rate. We conclude that the clear antirenin action of practolol and its cardioselectivity make this a drug of choice in the treatment of hypertension which is resistant to hemodialysis treatment.
Serum complement pattern in human glomerulonephritis. A. Tarantino, R. Ponti, G. BanJi', L. Guerra and E. Rivolta. Sezione di Nefrologia e Dialisi, Ospedale Maggiore di Milano, Ospedale Policlinico, Italy. Hypocomplementemia has long been known in human glomerulonephritis. More recently, two pathways of complement activation (the classic and the alternate one) have been described. Many workers have attempted to clarify' the specific complement activation pathway of different forms of glomerulonephritis; but agreement has not been achieved. In this study measurement of complement hemolytic activity and of protein concentrations by radial immunodiffusion of Clq, C4, C3, C3A and Cl INA have been performed. Twenty healthy controls and 64 patients (80 results) with various forms of gbmerulonephritis have been tested. In the patients with minimal change nephrotic syndrome (four cases), focal giomeruloscierosis (four cases), membranous nephropathy (six cases), focal proliferative glomerulonephritis eight cases) and glomerulonephritis with rheumatoid purpura (two cases), the indexes which were determined were in the normal range. Eight out of 18 cases of membranoproliferative glomerulonephritis showed a depression of CH5O titer, C3 and C3A component; the others showed a normal pattern. In 12 out of 23 cases of active systemic lupus erythematosus, in 9 out of 1! cases of glomerulonephritis with essential cryoglobulinemia and in 2 Out of 4 cases of acute glomerulonephritis, the uniform depression of all complement components has been established. In conclusion: a limited number of cases of glomerulonephritis show changes of complement.
Complement activation almost entirely occurs through the classical pathway. In some cases of membranoproliferative gbomerulonephritis, complement activation is likely to occur through the alternate pathway; indeed, CH5O, C3 and C3A concentrations are low, but Clq and C4 concentrations are normal; a feedback mechanism probably affects the classic pathway and C3A system. In fact, the lowest C3A concentrations are associated with the lowest CH5O, Clq, C4 and C3 concentrations.
Evidence for renal incapacity to extract glutamine in the production of ammonia in chronic renal failure. A. Tizianello, G. De Ferrari, G. Gurreri, I. Bertocchi and G. Garibotto (with the technical assistance of M. Bruzzone). Cattedra di C/mica Medica, 1st it uto Scientifico di Medicina Interna deli' Università di Genova, Italy. The arteriovenous difference across the kidney of glutamine and ammonia was measured in five patients with renal failure and metabolic acidosis (GFR ranging from 18 to 41 ml! mm). The renal extraction of glutamine was I zmo1e/min (from -3.0 to + 4.6 p. moles/mm) although the total production of ammonia (NH3 excreted with the urine + NH3 added to the renal vein) was 23 p.moles/min (values ranging from 13.4 to 40.5 p.moles/min). Even if both the amide and amino groups of glutamine are utilized for ammonia production, the extraction of glutamine in the kidney can account for only 10% of the total ammonia produced. The defective renal glutamine extraction for ammonia production in this pathologic condition is confirmed by the small increase of ammonia in the urine (+20%, NS) after i.v. infusion of glutamine. On the contrary, this treatment induces a significant increase in ammonia excretion (+ 80%, statistically significant) in subjects with normal renal function and metabolic acidosis of the same degree. Preliminary studies show that in chronic renal failure and metabolic acidosis, neither glutamate nor alanine nor asparagine is used as an alternative substrate.
Effect of indomethacin on renal function. M. Usberti, M. Mileti and R. Maiorca. Divisione Nefrologica Spedali Clviii di Brescia, Italy. Indomethacin has been suggested to be an effective drug for treating glomerulonephritis. Recent reports, however, underline unwanted effects of this drug on renal function (e.g., fall in glomerular filtration rate, GFR). Short-term experiments were carried out in 15 subjects (9 in antidiuresis and 6 during water diuresis) with normal GFR, to evaluate the effect of indomethacin on renal function. After a 200-mg i.v. injection of indomethacin, a marked and stable fall in GFR, urine flow and Na and Cl -excretion was observed; renal plasma flow fell initially, with a fall in filtration fraction, but then rose to the control values. During water diuresis a linear relationship was observed between C1120 and distal delivery of Na + (CNO, + C1120). No relationship could be detected between C1120 and GFR. These results suggest a direct effect of indomethacin on active sodium transport in the proximal convolution, enhancing proximal tubular reabsorption.
